title: Characterization of influenza virus NS1 protein by using a novel helper-virus-free reverse genetic system.
abstract: We have developed a novel helper-virus-free reverse genetic system to genetically manipulate influenza A viruses. The RNPs, which were purified from the influenza A/WSN/33 (WSN) virus, were treated with RNase H in the presence of NS (nonstructural) cDNA fragments. This specifically digested the NS RNP. The NS-digested RNPs thus obtained were transfected into cells together with the in vitro-reconstituted NS RNP. The NS-digested RNPs alone did not rescue viruses; however, cotransfection with the NS RNP did. This protocol was also used to rescue the NP transfectant. We obtained two NS1 mutants, dl12 and N110, using this protocol. The dl12 NS gene contains a deletion of 12 amino acids at positions 66 to 77 near the N terminus. This virus was temperature sensitive in Madin-Darby bovine kidney (MDBK) cells as well as in Vero cells. The translation of all viral proteins as well as cellular proteins was significantly disrupted during a later time of infection at the nonpermissive temperature of 39 degrees C. The N110 mutant consists of 110 amino acids which are the N-terminal 48% of the WSN virus NS1 protein. Growth of this virus was significantly reduced at any temperature. In the virus-infected cells, translation of the M1 protein was reduced to 10 to 20% of that of the wild-type virus; however, the translation of neither the nucleoprotein nor NS1 was significantly interfered with, indicating the important role of NS1 in translational stimulation of the M1 protein.
authors.affiliation: Department of Biochemistry, Kanazawa University School of Medicine, Takaramachi, Kanazawa, Ishikawa 920-8640, Japan. menami@med.kanazawa-u.ac.jp
authors.forename: M
authors.initials: M
authors.lastname: Enami
authors.forename: K
authors.initials: K
authors.lastname: Enami
mesh_terms: D000818:Animals; D002417:Cattle; D002460:Cell Line; D002522:Chlorocebus aethiops; D018076:DNA, Complementary / Q000235:genetics; D005816:Genetic Complementation Test; D016679:Genome, Viral; D006378:Helper Viruses / Q000502:physiology*; D009980:Influenza A virus / Q000235:genetics* / Q000254:growth & development / Q000378:metabolism / Q000502:physiology; D009154:Mutation / Q000235:genetics*; D019590:Nucleocapsid Proteins; D009698:Nucleoproteins / Q000096:biosynthesis; D014176:Protein Biosynthesis / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D012367:RNA, Viral / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D016601:RNA-Binding Proteins; D016914:Ribonuclease H / Q000378:metabolism; D017384:Sequence Deletion / Q000235:genetics; D013696:Temperature; D014158:Transcription, Genetic / Q000235:genetics; D014162:Transfection / Q000379:methods*; D014709:Vero Cells; D014758:Viral Core Proteins / Q000096:biosynthesis; D014763:Viral Matrix Proteins / Q000096:biosynthesis; D017361:Viral Nonstructural Proteins / Q000096:biosynthesis / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*; D014779:Virus Replication / Q000235:genetics
chemical_list: D018076:DNA, Complementary; C085820:INS1 protein, influenza virus; C031540:M-protein, influenza virus; C488936:M1 protein, Influenza A virus; C048842:NP protein, Influenza A virus; D019590:Nucleocapsid Proteins; D009698:Nucleoproteins; D012333:RNA, Messenger; D012367:RNA, Viral; D016601:RNA-Binding Proteins; D014758:Viral Core Proteins; D014763:Viral Matrix Proteins; D017361:Viral Nonstructural Proteins; D016914:Ribonuclease H